Last update 01 Nov 2024
Beijing Jiashi Lianbo Medicine Technology Co., Ltd.

Beijing Jiashi Lianbo Medicine Technology Co., Ltd.

Private Company|
2007|
Beijing Shi, China
|
www.jslb-bj.com

Overview

Tags

Otorhinolaryngologic Diseases
Immune System Diseases
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases1
Immune System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
M1 receptor x M3 receptor1

Related

2
Drugs associated with Beijing Jiashi Lianbo Medicine Technology Co., Ltd.
Bencycloquidium Bromide
Target
M1 receptor x M3 receptor
Mechanism
M1 receptor antagonists [+1]
Active Org.
Beijing Sciecure Pharmaceutical Co., Ltd.Beijing Sciecure Pharmaceutical Co., Ltd. [+4]
Originator Org.
Silver Valley Pharmaceutical Co. Ltd.Silver Valley Pharmaceutical Co. Ltd.
Active Indication
Rhinitis, Allergic [+4]
Inactive Indication
Rhinitis, Allergic, Perennial
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date17 Mar 2020
Iso-phenylcyclopentylamine Hydrochloric
Target
DAT x NET x SERT
Mechanism
Dopamine reuptake inhibitors [+2]
Active Org.-
Originator Org.
Silver Valley Pharmaceutical Co. Ltd.Silver Valley Pharmaceutical Co. Ltd.
Active Indication-
Inactive Indication
Obesity
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
8
Clinical Trials associated with Beijing Jiashi Lianbo Medicine Technology Co., Ltd.
CTR20212431 / CompletedPhase 1
苯环喹溴铵吸入气雾剂单次给药人体药代动力学和药效学临床试验
[Translation] Clinical trial on the pharmacokinetics and pharmacodynamics of single-dose bencyclidine bromide inhalation aerosol in humans
CTR20150359 / Active, not recruitingPhase 1
苯环喹溴铵吸入气雾剂 药代动力学临床试验
[Translation] Clinical trial of pharmacokinetics of bencyclidine bromide inhalation aerosol
CTR20130565 / Active, not recruitingPhase 1
苯环喹溴铵吸入气雾剂 耐受性临床试验
[Translation] Clinical trial on the tolerability of phenylcyclamate inhalation aerosol
100 Clinical Results associated with Beijing Jiashi Lianbo Medicine Technology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Beijing Jiashi Lianbo Medicine Technology Co., Ltd.
Login to view more data
100 Deals associated with Beijing Jiashi Lianbo Medicine Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Beijing Jiashi Lianbo Medicine Technology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Bencycloquidium Bromide
 ( M1 receptor x M3 receptor )		-
Phase 1
Iso-phenylcyclopentylamine Hydrochloric
 ( DAT x NET x SERT )		Obesity
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free